Chagee Holdings Ltd.
No SEC Form 4 filings for $CHA in the last 30 days.
See all $CHA insider activity →Chagee Holdings (CHA) shares rose following an upgrade to Buy from Hold by Jefferies. Analyst Lisa Liao cited improving same-store sales growth in China, indicating confidence in management's execution.
Chagee (CHA) reported Q2 2026 earnings with net revenues of RMB 3,414.6 million, up 2.5% YoY. Company-owned teahouse revenue surged 222.2% YoY, while total GMV fell 3.3% sequentially. Overseas GMV grew 114.3% YoY. GAAP operating income increased 387.6% due to cost management. Management highlighted economic headwinds and competition in Greater China but emphasized high-quality growth and overseas expansion.
Chagee Holdings Limited reported its 14th consecutive quarter of positive net income, with a non-GAAP G&A expense ratio declining to 9.1% from 13.2% year-over-year. The company is shifting its strategy to focus on consumer comfort, product diversification, and operational efficiency. Management expects same-store sales to turn positive in August, driven by new product launches and summer seasonality. A share repurchase program of up to USD 150 million is underway, with USD 30 million executed as
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning CHA (Chagee Holdings Ltd.). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent CHA coverage spans earnings, financial news and technology.
Analyst upgrade likely lifts sentiment and attracts buying interest.
Strong profit margin expansion and buyback signal may support short-term upside.
Chagee Holdings Limited reported its 14th consecutive quarter of positive net income, with a non-GAAP G&A expense ratio declining to 9.1% from 13.2% year-over-year. The company is shifting its strategy to focus on consumer comfort, product diversification, and operational efficiency. Management expects same-store sales to turn positive in August, driven by new product launches and summer seasonality. A share repurchase program of up to USD 150 million is underway, with USD 30 million executed as
Earnings beat on operating income but margins fell; cash balance declined, indicating mixed short‑term outlook.
The voucher is a new, funded initiative that could improve CHA Biotech’s CMC regulatory workflow efficiency, but it is not yet a quantified revenue or approval catalyst.
AlphAI scores every news story that mentions CHA with an AI model for sentiment and relevance, and aggregates insider trades from Chagee Holdings Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Chagee Holdings (CHA) shares rose following an upgrade to Buy from Hold by Jefferies. Analyst Lisa Liao cited improving same-store sales growth in China, indicating confidence in management's execution.
1 min readChagee (CHA) reported Q2 2026 earnings with net revenues of RMB 3,414.6 million, up 2.5% YoY. Company-owned teahouse revenue surged 222.2% YoY, while total GMV fell 3.3% sequentially. Overseas GMV grew 114.3% YoY. GAAP operating income increased 387.6% due to cost management. Management highlighted economic headwinds and competition in Greater China but emphasized high-quality growth and overseas expansion.
2 min readChagee Holdings Limited reported its 14th consecutive quarter of positive net income, with a non-GAAP G&A expense ratio declining to 9.1% from 13.2% year-over-year. The company is shifting its strategy to focus on consumer comfort, product diversification, and operational efficiency. Management expects same-store sales to turn positive in August, driven by new product launches and summer seasonality. A share repurchase program of up to USD 150 million is underway, with USD 30 million executed as
3 min readChagee Holdings Ltd. (CHA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Chagee Announces Second Quarter 2026 Unaudited Financial Results SHANGHAI, August 28, 2026 (GLOBE NEWSWIRE) -- Chagee Holdings Limited (NASDAQ: CHA) (“Chagee” or the “Company”), a leading premium tea drinks brand serving healthy and delicious freshly-made tea drinks,
3 min readCHA Biotech said it was selected for South Korea’s MSIT “AX One-Stop Voucher” to invest 2.6 billion won in an AI-SaaS system that automates drafting and verification of cell-therapy regulatory documents, especially CMC. The project will run via a consortium with Naver Cloud, Persona AI, and MedAI Plus.
3 min readChagee Holdings (NASDAQ:CHA) traded about 517,649 shares on Monday, down 12% from the prior session. The stock last traded at $13.0420 vs. $12.76 close. Analysts cited mixed views: Morgan Stanley set $15.50 (overweight), JPMorgan raised to $16.00 (overweight), while Weiss (sell) and Zacks (strong sell) cut ratings.
3 min readChagee Holdings (NASDAQ: CHA) reported first-quarter 2026 unaudited results for the period ended March 31, 2026. Net revenues rose to RMB3,546.0 million (US$514.1 million) from RMB3,392.7 million a year earlier, but operating income fell to RMB547.2 million and GAAP net income to RMB447.7 million. Total GMV was RMB7,917.8 million; teahouses increased 12.7% to 7,531. The company also authorized a US$150 million share repurchase program.
4 min readThe article previews a short U.S. and Canada market week after Memorial Day, highlighting housing, confidence, jobs, and earnings. It lists U.S. EPS results for PDD, AutoZone, Elbit, Salesforce, Synopsys, Marvell, Costco, Dell, and Autodesk, plus Canada banks’ and other firms’ EPS. Key data include S&P Case-Shiller (March), jobless claims and durable goods (May 23/April), and Canada payroll employment and GDP.
2 min readChagee, the Chinese milk tea chain, announced plans to expand into South Korea with three flagship stores in Seoul set to open this year. The expansion signifies the company's continued growth strategy.
3 min readJohnson Fistel, PLLP is investigating Chagee Holdings (NASDAQ: CHA) for potential securities law violations after the company's Q2 financial results, disclosed on August 29, 2025, led to a sharp decline in stock price and investor losses. The decline was attributed to increased competitive pressures and rising costs impacting performance. Johnson Fistel is encouraging affected investors to inquire about recovery options.
4 min read
